SD HEALTHCARE

Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...

Arthritis Drug Is Big Test for Samumed

MEDICINE: Co. Following Own Path on Investors, ValuationSamumed emerged two years ago with a mission of regenerating hair, skin and joints, valued at a head-turning $12 billion.

DJO Global Acquired for $3.15 Billion

Change is blowing through DJO Global, after the medical device company announced plans this summer to relocate from San Diego to Texas. Then came news on Nov. 19 that DJO was acquired for $3.15 billion.

Cibus Files for $100M IPO

Cibus – a San Diego company that uses gene editing to select desirable plant traits – is seeking $100 million through an initial public offering.

Ehrich Named CMO of Expansion Therapeutics

Elliot Ehrich, previously with Alkermes Plc, is the new chief medical officer of San Diego biotech startup Expansion Therapeutics.

Report: Jobs Increase in Life Sciences Sector

Employment in the life sciences sector in San Diego County rose 15.4 percent year over year, according to a recent report.

Arena Nets $800M Upfront in Licensing Deal

Arena Pharmaceuticals on Nov. 15 announced a drug licensing deal that provides the company with ample cash to devote to other medicines in its pipeline.

OncoSec’s Korean Ties Draw Attention in U.S. and S. Korea

Japan sticks out as San Diego biotech’s most valuable international trading partner. Elsewhere in Asia, regional biotechs like Tocagen are gaining a foothold in China through partnerships with Chinese firms.

StemGenex’s Marketing, Manufacturing Draw FDA Warning

StemGenex Biologic Laboratories recently drew a warning letter from the U.S. Food and Drug Administration over manufacturing practices and the marketing of an unapproved stem cell therapy.

Synthorx Files for $100M IPO

With a pipeline that activates tumor-fighting immune cells, Synthorx looks to raise $100 million through an initial public offering.

Scientist.com to Open an Office in Japan

The San Diego-based company recently experienced growth in its Japanese clientele, which includes several large pharmaceuticals.

NIH Grant Puts Wind in Kaer Biotherapeutics’ Sails

Kaer Biotherapeutics of Escondido received a $2 million grant from the National Institutes of Health to help develop a device for people who can't breathe.